A team of scientists at the Cambridge-based Whitehead Institute for Biomedical Research have identified a compound that can reverse some of the toxicity that occurs in brain cells created from Parkinson’s disease patients’ stem cells. Dennis Selkoe, professor of neurologic diseases at Brigham and Women’s Hospital, and Vikram Khurana, instructor in neurology at MGH, are quoted.
